Single-use vendors will continue benefiting from Biopharma demand, expert
Vendors have again reported high growth in sales of single-use systems and according to Eric Langer from BioPlan Associates this trend is set to continue.
Vendors have again reported high growth in sales of single-use systems and according to Eric Langer from BioPlan Associates this trend is set to continue.
Cell therapy firm Bellicum Pharmaceuticals has entered a ten-year agreement for the supply of BioLife Solutions’ cryopreservation media.
Catalent and Zumutor Biologics have combined their technologies to create antibodies with enhanced Antibody Dependent Cellular Cytotoxicity (ADCC) without compromising production levels.